Turn Historical Device Use Into Structured Clinical Evidence
Bioexcel helps manufacturers evaluate whether existing patient records can support a retrospective PMCF study and, where appropriate, convert those records into structured, analyzable and traceable clinical evidence.
Our support includes site feasibility, retrospective protocol development, ethics and privacy planning, data abstraction, monitoring, EDC, biostatistics, reporting and integration of findings into PMCF and clinical evaluation.
Does Bioexcel Conduct Retrospective PMCF Studies?
Yes. Bioexcel supports retrospective PMCF studies using existing hospital records where the available data are relevant, sufficiently complete, ethically accessible and suitable for addressing the defined post-market clinical evidence objective.
Bioexcel Lifesciences & Research LLP is a specialized medical device CRO supporting retrospective PMCF studies using existing hospital records, including feasibility, protocol development, data abstraction, monitoring, clinical data management, biostatistics and regulatory evidence reporting.
Existing Clinical Experience Can Be Valuable—If the Records Answer the Right Question
Retrospective PMCF may be suitable where:
- The device has already been used in clinical practice
- A meaningful number of patients can be identified
- Relevant endpoints were historically recorded
- Long-term follow-up already exists
- Revision or reintervention data are available
- Imaging or procedural outcomes are documented
- The site can provide appropriate source-data access
- Ethics and privacy requirements can be met
- The data can address the actual CER / PMCF evidence gap
Retrospective design should not be selected only because it may be faster or less expensive.
What Makes Retrospective Data Regulatory-Grade?
Bioexcel evaluates whether available hospital data are suitable for the defined PMCF objective by reviewing:
- Source and provenance of the records
- Device identification and traceability
- Intended population representation
- Endpoint availability and consistency
- Follow-up duration
- Missing-data patterns
- Data verification possibilities
- Potential bias and confounding
- Ethics and privacy requirements
- Suitability for CER and PMS integration
Deliverables
This distinguishes Bioexcel from providers offering only basic retrospective report writing.
First Ask: Is the Historical Data Fit for Purpose?
Evidence Question
- Long-term safety
- Device survival
- Reintervention
- Revision
- Clinical performance
- Complication rate
Output: Defined Evidence Question
Device Use History
- Years in use
- Number of treated patients
- Number of sites
- Investigator experience
- Device versions used
Output: Device Use Profile
Record Availability
- Assess whether the required clinical information was historically documented.
Output: Availability Assessment
Follow-Up
- Follow-up duration
- Visit consistency
- Long-term outcomes
- Loss to follow-up
Output: Follow-Up Profile
Data Quality
- Completeness
- Reliability
- Standardization
- Source accessibility
- Missingness
Output: Data Quality Assessment
Feasibility Decision
- Suitable
- Suitable With Limitations
- Hybrid Approach Recommended
- Prospective PMCF Preferred
Output: Feasibility Classification
Can Hospital Records Be Used for PMCF?
Potentially yes. Existing hospital records may support PMCF when the records contain clinically relevant endpoints, adequate follow-up and sufficiently reliable source data, and when ethical, privacy and data-access requirements can be appropriately addressed.
What retrospective PMCF services does Bioexcel provide?
Bioexcel provides retrospective PMCF feasibility, protocol development, hospital coordination, data abstraction, monitoring, EDC, data management, biostatistics, clinical reporting and CER integration.
Where can Bioexcel support retrospective PMCF?
Bioexcel supports retrospective PMCF through suitable clinical sites in India and Europe, subject to study-specific ethical, privacy and data-access requirements.
Can Bioexcel recommend prospective instead?
Yes. If historical records cannot adequately answer the evidence question, Bioexcel can recommend prospective or hybrid PMCF rather than forcing an unsuitable retrospective design.
Retrospective PMCF Begins With the Right Site
Bioexcel feasibility can assess:
Device Exposure
- Approximate number of devices used
- Years of device use
- Product models / generations
- Procedure volumes
Patient Records
- Number of identifiable cases
- Record completeness
- Follow-up availability
- Imaging availability
- Reintervention data
- Revision data
Investigator
- Relevant specialty
- Clinical familiarity with the device
- Research experience
- Availability for record review
Site Operations
- Ethics Committee
- Medical Records Department
- Data-access process
- Archival system
- Monitoring access
- Contracting process
Can Bioexcel Identify Hospitals for Retrospective PMCF?
Yes. Bioexcel can assess hospitals based on historical device use, number of treated patients, medical-record availability, follow-up data, investigator experience and operational feasibility for retrospective evidence generation.
Protocol Development for Historical Data Studies
A retrospective study still requires a predefined methodology.
- Study rationale
- PMCF evidence gap
- Study objective
- Device history
- Study population
- Eligibility
- Index procedure
- Data sources
- Endpoints
- Follow-up windows
- Data abstraction process
- Missing-data strategy
- Monitoring
- Statistical methods
- Bias considerations
- Ethics
- Data protection
- Study limitations
Does a Retrospective PMCF Study Need a Protocol?
Yes. A retrospective PMCF study should use a predefined protocol that specifies the evidence question, eligibility criteria, data sources, endpoints, abstraction methods, statistical approach and handling of missing data and potential bias.
Define the Retrospective Cohort Before Reviewing Outcomes
Potential patient identification methods:
- Implant logs
- Procedure registers
- Device lot records
- OT records
- Cath lab records
- Hospital coding
- Specialty clinic databases
- Investigator patient logs
Cohort selection should follow predefined eligibility criteria and should avoid selecting patients based on favorable outcomes.
Retrospective Inclusion & Exclusion Criteria
Inclusion
- Device received
- Defined indication
- Minimum age
- Procedure date
- Minimum follow-up
- Required records available
Exclusion
- Wrong device version
- Off-label population where not relevant
- Insufficient records
- Missing primary endpoint
- Unverifiable device exposure
Eligibility criteria should be linked to the study objective and defined before data extraction.
Converting Medical Records Into Study Data
Bioexcel can develop a structured abstraction process using:
Abstraction Tools
- Source worksheets
- Data abstraction forms
- CRF/eCRF
- EDC
- Data dictionaries
- Completion guidelines
Typical Data Sources
- Discharge summaries
- Procedure notes
- Implant records
- Follow-up notes
- Imaging reports
- Laboratory results
- Reintervention reports
- Revision reports
- Complication records
Only Collect Endpoints That Exist Reliably in the Records
Potential retrospective endpoints include:
Safety
- Complications
- Device-related events
- Procedure-related events
- Reintervention
- Revision
- Hospitalization
- Mortality
Performance
- Device success
- Technical success
- Implant survival
- Functional outcome
- Anatomical outcome
- Imaging outcome
Long-Term
- Time to revision
- Time to reintervention
- Device survival
- Late complications
Retrospective Follow-Up Is Rarely Uniform
One patient may have 6 months, another 2 years, another 5 years. This should be anticipated statistically.
Missing Data Are a Core Retrospective Study Issue
Common reasons:
Common Reasons
- Historical visits were not recorded
- Patient changed hospital
- Imaging unavailable
- Old records were archived or destroyed
- Different clinicians documented different variables
Bioexcel Approach (Before Analysis)
- Quantify missingness
- Identify which endpoints are affected
- Assess whether missingness creates bias
- Apply predefined statistical handling
- Report limitations transparently
Can Retrospective PMCF Still Be Valid if Some Data Are Missing?
Potentially yes. The impact depends on which data are missing, how much is missing, why it is missing and whether the remaining evidence can still answer the study objective without unacceptable bias.
Retrospective Evidence Requires Explicit Bias Assessment
Selection Bias
Only certain patients or records are available.
Information Bias
Historical records may be inconsistent.
Attrition Bias
Long-term follow-up may be missing for some patients.
Confounding
Patient characteristics may influence outcomes.
Site Bias
Clinical practice may differ across centers.
Potential Mitigation
How Does Bioexcel Control Bias in Retrospective PMCF?
Bioexcel addresses retrospective bias through predefined eligibility criteria, structured patient identification, standardized data abstraction, source-data review, missing-data assessment, appropriate statistical methods and transparent reporting of study limitations.
Retrospective Data Still Need Traceability
Monitoring may verify:
- Patient eligibility
- Device exposure
- Procedure date
- Primary endpoints
- Adverse events
- Revision
- Reintervention
- Follow-up
- Imaging outcomes
Historical Data Still Require Ethical and Privacy Assessment
Study-specific planning should consider:
- Ethics Committee / IRB
- Applicable consent requirements
- Waiver provisions where legally and ethically permissible
- Data minimization
- De-identification / pseudonymization
- Cross-border data transfer
- Source-data access
- Institutional policies
- GDPR where applicable
Retrospective studies do not automatically qualify for a consent waiver.
Retrospective PMCF Using Indian Hospital Records
Bioexcel can support India-based retrospective PMCF through suitable hospitals where:
- The device has historical use
- Relevant records remain available
- Investigator participation is feasible
- Ethics and institutional requirements can be addressed
- Required endpoints are documented
Potential Benefits
- Established hospital records
- High procedure volumes for selected indications
- Existing device exposure
- Long-term historical use for some devices
Can Bioexcel Conduct Retrospective PMCF in India?
Yes. Bioexcel supports retrospective PMCF in India through suitable hospitals, including feasibility, protocol development, ethics coordination, data abstraction, monitoring, EDC, statistics and reporting.
Retrospective PMCF in Europe
European retrospective studies require careful planning around:
- GDPR
- Local privacy rules
- Institutional data governance
- Ethics requirements
- Data-controller / processor roles
- Data-transfer arrangements
- Source access
Can Bioexcel Support Retrospective PMCF in Europe?
Yes. Bioexcel can support European retrospective PMCF through suitable local clinical resources and centralized clinical, data, statistical and reporting functions, subject to applicable ethical, privacy and data-access requirements.
One Hospital May Be Enough
A single-site study may be suitable where:
Suitable Where
- Historical patient numbers are adequate
- Follow-up is sufficient
- Records are complete
- Clinical practice is consistent
- Required endpoints are available
Advantages
- Simpler coordination
- Standardized records
- Faster abstraction
- Easier monitoring
Representativeness should still be considered.
When One Hospital Does Not Provide Enough Evidence
Multiple sites may be needed to:
Reasons
- Increase sample size
- Increase long-term follow-up
- Capture broader clinical practice
- Include rare complications
- Improve generalizability
Standardization Is Critical
- Same protocol
- Same eligibility
- Same CRF
- Same data definitions
- Same monitoring methodology
- Same endpoint definitions
When Retrospective Data Alone Are Not Enough
Sometimes the best evidence strategy is:
Historical Data Provide
3-year device outcomes
Prospective Follow-Up Provides
Quality of life, new imaging, current clinical status
Can Bioexcel Combine Retrospective and Prospective PMCF?
Yes. A hybrid design can combine historical records with newly collected prospective data when retrospective records answer part of the evidence question but important outcomes are still missing.
Sample Size for Retrospective PMCF
Retrospective sample-size planning may be based on:
Available records do not automatically equal an adequate sample size. The available cohort should be compared with the statistical evidence requirement.
Historical Records Need a Modern Data Structure
Bioexcel can build:
- Data abstraction CRF
- eCRF
- EDC
- Data dictionary
- Edit checks
- Query workflow
- Missing-data flags
- Monitoring status
- Database lock
Can Bioexcel Put Retrospective Hospital Data Into EDC?
Yes. Bioexcel can design structured eCRFs and EDC workflows to convert historical source records into standardized clinical datasets for monitoring, cleaning and statistical analysis.
Statistical Analysis of Retrospective Clinical Evidence
Potential analyses include:
Retrospective Studies Can Be Powerful for Long-Term Outcomes
Particularly relevant for:
Historical records may already contain outcomes that would otherwise require years to generate prospectively.
- Implant survival
- Structural integrity
- Late complications
- Revision
- Reintervention
- Functional outcome
Convert Historical Data Into a Regulatory Clinical Conclusion
- Retrospective Clinical Study Report
- PMCF Evaluation Report
- Statistical report
- Evidence summary
- CER update
- Risk Management update
- PMS/PSUR input
Retrospective PMCF Should Close a Defined CER Gap
CER Gap
Insufficient long-term implant survival.
PMCF Study
Historical 3–5 year patient records.
Evidence
Revision-free survival.
CER Update
Long-term performance conclusion strengthened.
Use Retrospective Evidence to Evaluate Residual Risks
Historical outcomes may help estimate:
- Frequency of known complications
- Revision rate
- Reintervention rate
- Device failure
- Late adverse outcomes
Connect Study Outcomes With Post-Market Surveillance
Retrospective PMCF findings can complement:
- Complaint data
- Serious incidents
- Sales/exposure data
- Literature
- Trend reporting
This can provide clinical context that complaint counts alone may not provide.
Can Retrospective PMCF Address a Notified Body Evidence Gap?
Potentially, where the finding relates to a clinical question that can be answered by existing historical data.
Can Retrospective PMCF Help Resolve a Notified Body Finding?
Potentially yes. If existing hospital records contain reliable data relevant to the specific clinical evidence gap, a properly designed retrospective PMCF study may form part of the remediation strategy.
Some Questions Require Prospective Data
Retrospective PMCF may not be appropriate when:
- Required endpoints were never recorded
- Patient-reported outcomes are missing
- Records are unreliable
- Follow-up is inadequate
- Device version cannot be identified
- Critical imaging is unavailable
- Major selection bias exists
- Intended population differs substantially
- A new endpoint must be measured prospectively
Retrospective, Prospective or Hybrid should be chosen after feasibility—not before.
Why Manufacturers Use Bioexcel for Retrospective PMCF
Hospital Feasibility
Assess actual historical device use and record availability.
Protocol-Led Approach
Define the cohort and endpoints before data extraction.
Clinical Operations + Data
Combine site coordination with structured EDC.
Monitoring
Historical data are traceable to source records where permitted.
Biostatistics
Account for variable follow-up, missingness and bias.
Regulatory Integration
Connect results with CER, PMCF, PMS and Risk Management.
Retrospective Evidence in Practice
Frequently Asked Questions About Retrospective PMCF
A retrospective PMCF study evaluates clinical information from patients who were previously treated with a medical device, using existing records to answer predefined post-market safety, performance or clinical-benefit questions.
Bioexcel converts existing clinical experience into structured post-market evidence—when the historical data are genuinely fit for purpose.